Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 192
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT01658930 | Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT01567137 | MR Characterisation/Localisation of Breast Cancer | ||
| NCT00499174 | Observation or Radical Treatment in Patients With Prostate Cancer | ||
| NCT00787514 | FR in Stored Plasma | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT05375591 | AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer | ||
| NCT06868355 | APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials | ||
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC | ||
| NCT02429427 | European Celecoxib Trial in Primary Breast Cancer | ||
| NCT00079248 | Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer | ||
| NCT06423976 | Microbiome Molecular Charaterisation | ||
| NCT04763317 | Precision Medicine in the Prostate Cancer Care Pathway | ||
| NCT02753569 | Imaging NSCLC Treatment Response to Immunotherapy | ||
| NCT02543905 | The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT03727698 | Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment | ||
| NCT00867347 | Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer | ||
| NCT04648033 | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | ||
| NCT03809377 | Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2) | ||
| NCT06409221 | VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT05368298 | SCOOT: Sample Collection for DART | ||
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | ||
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations | ||
| NCT06396754 | Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC | ||
| NCT03574454 | Machine Learning in Myeloma Response | ||
| NCT04458311 | Abiraterone Acetate in Combination With Tildrakizumab | ||
| NCT04065269 | ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss | ||
| NCT02437227 | Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833 | ||
| NCT03256981 | Stereotactic Body Radiotherapy for the Treatment of OPD | ||
| NCT03795272 | Rucaparib Maintenance Therapy in Advanced Cervical Cancer | ||
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study | ||
| NCT07498829 | Population Based Germline Testing for Early Detection and Prevention of Cancer | ||
| NCT02955082 | The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment | ||
| NCT06975579 | The COherence of Scatter Identification and Exclusion Algorithm Study | ||
| NCT02388308 | Evaluation of Clarity Ultrasound Guidance for Prostate Therapy | ||
| NCT04595019 | Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer | ||
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | ||
| NCT07741929 | Patient and Provider Perspectives on Genetic Risk Profiling | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT00045045 | Positron Emission Tomography in Detecting Testicle Cancer | ||
| NCT06470685 | Prophylactic Prostatectomy for Prostate Cancer (PPPC) | ||
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | ||
| NCT02338622 | Trial of Olaparib in Combination With AZD5363 (ComPAKT) | ||
| NCT00053092 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma | ||
| NCT02126800 | Rapid Medical Donation Programme for Breast Cancer | ||
| NCT04686188 | Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer |
